Johnson & Johnson annual research and development expenses for 2023 were $15.085B, a 6.72% increase from 2022. Johnson & Johnson annual research and development expenses for 2022 were …

Johnson & Johnson and its subsidiaries (the Company) have approximately 152,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of …

Feb 17, 2025 · In 2024, Johnson & Johnson spent more than 17 billion U.S. dollars on research and development. This is a significant increase compared to 2014 when the company spent 8.5 billion …

The print and digital publications we produce each year that recap the company’s business performance and key enterprise-wide milestones.

Jan 3, 2021 · Johnson & Johnson's r&d expenses hit its 5-year low in January 2021 of 12.34 billion. Johnson & Johnson's r&d expenses decreased in 2023 (14.918 billion, -1.7%) and increased in 2021 …

Dec 31, 2024 · In depth view into Johnson & Johnson Research and Development Expense (Annual) including historical data from 1990, charts and stats.

These expenses followed a pattern of increase from 22,084 million in 2020 to 24,765 million in 2022, followed by a significant decrease to 21,512 million in 2023, before rising again to 22,869 million in …

Jan 2, 2022 · Management and representatives of Johnson & Johnson and its subsidiaries (the Company) also may from time to time make forward-looking statements.

Johnson & Johnson Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending July 03, 2022 was USD 15.92 B, a 18.39% change year over year.

Aug 22, 2023 · In 2022, AbbVie ranked the top among the companies spending on R&D with a total R&D expense of $55B followed by Roche and Johnson & Johnson with $15.20B and $14.60B …